A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy

There are clinical challenges related to adjuvant treatment in colorectal cancer (CRC) and novel molecular markers are needed for better risk stratification of patients. Our aim was to integrate our previously reported clinical-genetic prognostic score with new immunogenetic markers of 5-year diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mattia, Elena, Dreussi, Eva, Montico, Marcella, Gagno, Sara, Zanusso, Chiara, Quartuccio, Luca, De Vita, Salvatore, Guardascione, Michela, Buonadonna, Angela, D’Andrea, Mario, Pella, Nicoletta, Favaretto, Adolfo, Mini, Enrico, Nobili, Stefania, Romanato, Loredana, Cecchin, Erika, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180157/
https://www.ncbi.nlm.nih.gov/pubmed/30337874
http://dx.doi.org/10.3389/fphar.2018.01101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180157/
https://www.ncbi.nlm.nih.gov/pubmed/30337874
http://dx.doi.org/10.3389/fphar.2018.01101

Ejemplares similares